Literature DB >> 18448795

Advanced glycation end product homeostasis: exogenous oxidants and innate defenses.

Helen Vlassara1, Jaime Uribarri, Weijing Cai, Gary Striker.   

Abstract

Increased oxidative stress (OS) underlies many chronic diseases prevalent in aging. Data in humans confirm the hypothesis that advanced glycation end products (AGEs) and other oxidants derived from the diet may be major contributors to increased OS in normal adults as well as those with diabetes mellitus or kidney failure. Mice fed a diet with a lowered (approximately 50%) content of AGEs or a typical calorie-restricted (CR) diet, accumulated a smaller amount of AGEs, maintained normal levels of AGE receptor-1 (AGER1), and did not have increased oxidant stress or cardiac or kidney fibrosis with aging. However, the findings in mice fed a CR diet with an increased content of AGEs resembled those in mice fed a nonrestricted diet that had the usual higher content of AGEs. Thus, there was an inverse correlation between the dietary AGE content, the AGER1 to receptor for AGE (RAGE) ratio, OS, organ damage, and life span. In both humans and mice, there was an inverse correlation between the AGER1 to RAGE ratio and the levels of OS.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18448795     DOI: 10.1196/annals.1433.055

Source DB:  PubMed          Journal:  Ann N Y Acad Sci        ISSN: 0077-8923            Impact factor:   5.691


  30 in total

Review 1.  Uremic Toxicity of Advanced Glycation End Products in CKD.

Authors:  Andréa E M Stinghen; Ziad A Massy; Helen Vlassara; Gary E Striker; Agnès Boullier
Journal:  J Am Soc Nephrol       Date:  2015-08-26       Impact factor: 10.121

Review 2.  Red meat, dietary heme iron, and risk of type 2 diabetes: the involvement of advanced lipoxidation endproducts.

Authors:  Desley L White; Avril Collinson
Journal:  Adv Nutr       Date:  2013-07-01       Impact factor: 8.701

3.  Actin cytoskeletal rearrangement and dysfunction due to activation of the receptor for advanced glycation end products is inhibited by thymosin beta 4.

Authors:  Sokho Kim; Jungkee Kwon
Journal:  J Physiol       Date:  2015-02-27       Impact factor: 5.182

4.  Induction of diabetes in aged C57B6 mice results in severe nephropathy: an association with oxidative stress, endoplasmic reticulum stress, and inflammation.

Authors:  Jin Wu; Ruihua Zhang; Massimo Torreggiani; Adrian Ting; Huabao Xiong; Gary E Striker; Helen Vlassara; Feng Zheng
Journal:  Am J Pathol       Date:  2010-04-02       Impact factor: 4.307

5.  The role of actin depolymerizing factor in advanced glycation endproducts-induced impairment in mouse brain microvascular endothelial cells.

Authors:  Xinfeng Liu; Rongju Zhang; Hai Di; Dengfa Zhao; Jun Wang
Journal:  Mol Cell Biochem       Date:  2017-04-04       Impact factor: 3.396

Review 6.  Role of advanced glycation endproducts and potential therapeutic interventions in dialysis patients.

Authors:  Sandeep K Mallipattu; John C He; Jaime Uribarri
Journal:  Semin Dial       Date:  2012-04-30       Impact factor: 3.455

7.  AGER1 regulates endothelial cell NADPH oxidase-dependent oxidant stress via PKC-delta: implications for vascular disease.

Authors:  Weijing Cai; Massimo Torreggiani; Li Zhu; Xue Chen; John Cijiang He; Gary E Striker; Helen Vlassara
Journal:  Am J Physiol Cell Physiol       Date:  2009-12-02       Impact factor: 4.249

8.  Advanced glycation end products impair K(Ca)3.1- and K(Ca)2.3-mediated vasodilatation via oxidative stress in rat mesenteric arteries.

Authors:  Li-Mei Zhao; Yan Wang; Xiao-Zhen Ma; Nan-Ping Wang; Xiu-Ling Deng
Journal:  Pflugers Arch       Date:  2013-07-20       Impact factor: 3.657

9.  Parainflammation associated with advanced glycation endproduct stimulation of RPE in vitro: implications for age-related degenerative diseases of the eye.

Authors:  Tony Lin; Gregory Brett Walker; Khaliq Kurji; Edward Fang; Geoffrey Law; Shiv S Prasad; Luba Kojic; Sijia Cao; Valerie White; Jing Z Cui; Joanne A Matsubara
Journal:  Cytokine       Date:  2013-04-17       Impact factor: 3.861

Review 10.  Advanced glycation end product accumulation: a new enemy to target in chronic kidney disease?

Authors:  Sandeep K Mallipattu; Jaime Uribarri
Journal:  Curr Opin Nephrol Hypertens       Date:  2014-11       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.